Copyright © Inderes 2011 - present. All rights reserved.

Devyser Diagnostics

76.40 SEK

+0.66 %

Less than 1K followers

DVYSR

First North Stockholm

Medical Equipment & Services

Health Care

+0.66 %
-15.30 %
-33.10 %
-33.22 %
-45.58 %
-26.18 %
+9.14 %
-
-14.16 %

Devyser Diagnostics develops, manufactures, and sells genetic tests to laboratories globally. The products are used for DNA tests in oncology, transplantation, and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases, and follow-up of transplant patients. The company is headquartered in Hägersten.

Read more
Market cap
1.27B SEK
Turnover
394.85K SEK
Revenue
250.5M
EBIT %
4.03 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/4
2026

Interim report Q1'26

6/5
2026

General meeting '26

20/7
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.